Copyright
©The Author(s) 2015.
World J Gastroenterol. Jun 7, 2015; 21(21): 6621-6630
Published online Jun 7, 2015. doi: 10.3748/wjg.v21.i21.6621
Published online Jun 7, 2015. doi: 10.3748/wjg.v21.i21.6621
Table 2 Potential predictors of overall survival in 96 patients with pancreatic ductal adenocarcinoma undergoing radical surgery
| Variable | Univariate | Multivariate | ||
| P value | HR | 95%CI | P value | |
| Tumor diameter | 0.010 | 1.172 | 0.992-1.385 | 0.062 |
| T stage | 0.012 | 2.355 | 1.413-3.925 | 0.031 |
| Differentiation | 0.016 | 2.397 | 1.665-3.451 | < 0.001 |
| Perineural invasion | 0.076 | 2.236 | 1.163-4.300 | 0.016 |
| Rassf6 expression | 0.021 | 4.620 | 2.027-10.527 | 0.006 |
- Citation: Ye HL, Li DD, Lin Q, Zhou Y, Zhou QB, Zeng B, Fu ZQ, Gao WC, Liu YM, Chen RW, Li ZH, Chen RF. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival. World J Gastroenterol 2015; 21(21): 6621-6630
- URL: https://www.wjgnet.com/1007-9327/full/v21/i21/6621.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i21.6621